← Back

$ Value

$0

Shares

6,016

Price

$0

Filed

Jun 30

Insider

Name

Hoppenot Herve

Title

Special Advisor to the CEO

CIK

0001596492

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-26

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

569,589

Footnotes

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. | Including the June 26, 2025 grant, this includes an aggregate of 187,611 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. | The June 26, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. | Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ('TSR') over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date.

Filing Info

Accession No.

0001628280-25-033513

Form Type

4

Issuer CIK

0000879169

Hoppenot Herve's History

Date Ticker Type Value
2025-09-08 BCYC A $0
2025-09-08 BCYC A $0
2025-07-15 INCY F $322K
2025-07-14 INCY F $347K
2025-07-02 INCY F $2.9M
2025-06-26 INCY A $0
2025-06-26 INCY A $0
2025-06-26 INCY A $0

Other Insiders at INCY (90d)

Insider Bought Sold Last
HARRIGAN EDMUND 2026-03-31
CAGNONI PABLO J
President, Global Head of R&D
$1.8M 2026-04-17
BAKER BROS. ADVISORS LP 2026-03-31
Clancy Paul J 2026-03-31
Meury William
Chief Executive Officer
2026-04-15
Stein Steven H
CMO & Head of Late-Stage Dev.
2026-04-15
Trotta Matteo
EVP, GM, Dermatology US
2026-03-25